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Abstract 
D-cycloserine (DCS), a partial agonist that acts on the N-methyl-D-aspartate 
(NMDA) receptor of the glutamatergic receptor complex, may enhance fear extinction 
learning during exposure-based therapy.  Clinical studies in adults with obsessive-
compulsive disorder (OCD) and non-OCD anxiety disorders - and a recent trial in 
pediatric OCD - have shown that DCS can improve treatment response to exposure 
therapy relative to placebo and exposure therapy.  Some have hypothesized that improved 
treatment response is a function of increased compliance and engagement in therapeutic 
homework tasks, a core component of behavioral treatment. The present study examined 
the relationship between DCS and homework compliance in a 10-week, double-blind, 
placebo controlled DCS+CBT treatment trial with 30 children and adolescents with a 
primary diagnosis of OCD.  D-cycloserine was dosed 25 or 50mg (depending on weight) 
one hour before therapy sessions 4-10. Group status (DCS or placebo) did not predict 
improved homework compliance over the course of treatment. However, significant 
group differences in homework compliance were found at the first exposure session.   
Additionally, homework compliance mediated the relationship between DCS and 
treatment outcome.  When groups were collapsed, homework compliance was directly 
 iv
associated with treatment outcome. These findings suggest that outside the context of 
DCS, homework compliance is an integral part of OCD treatment. 
 1
 
 
 
Introduction 
Obsessive-compulsive disorder (OCD) is a chronic and disabling neuropsychiatric 
disorder that is characterized by the presence of recurrent obsessions and compulsions 
(American Psychiatric Association, 2000). Obsessions are persistent thoughts and images 
that are intrusive, unwanted, and distress-provoking.  Compulsions are repetitive 
behaviors or rituals that serve to either relieve or prevent the distress caused by the 
obsessions.  Obsessive-compulsive disorder tends to have its onset during childhood or 
adolescence (Berg et al., 1989), has a lifetime prevalence of 1-2% (Douglass, Moffitt, 
Dar, McGee, & Silva, 1995; Zohar, 1999), and is associated with marked impairments in 
psychosocial, academic, and family functioning (Lack et al., 2009; Piacentini, Bergman, 
Keller, & McCracken, 2003).  Additionally, childhood OCD is often accompanied by 
comorbid disorders including tic, anxiety, mood and behavioral disorders, which may 
further complicate course of illness and treatment (Geller et al., 2000; Geller et al., 1998; 
Storch et al., 2008).     
OCD Treatment 
Currently there are two empirically supported methods of treatment for childhood 
OCD: cognitive behavioral therapy with exposure and response prevention (CBT) and 
pharmacotherapy using serotonin reuptake inhibitors (SRIs).  Studies of pharmacological 
approaches in childhood OCD have consistently produced modest but positive results 
relative to placebo controls.  For example, Liebowitz et al. (2002), in a 16-week, placebo-
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controlled trial (n = 43; ages 6-18 years), found that fluoxetine was significantly more 
efficacious in reducing OCD symptoms than placebo.  Similarly, Geller et al. (2001) 
found in a 13-week, double-blind, placebo controlled trial (n = 103; ages 7-17 years) that 
fluoxetine was associated with significantly greater improvements in OCD than placebo.  
Paroxetine was also demonstrated superior to placebo in a 10-week randomized, placebo-
controlled trial (n = 203; ages 7-17 years; Geller et al., 2004).  Across studies, 
medications were generally well-tolerated and there were relatively few treatment 
discontinuations due to adverse events (Geller et al., 2001; Geller et al., 2004; Liebowitz 
et al., 2002).  Aggregating the extant findings, meta-analytic findings have demonstrated 
a medium effect size of 0.46 for selective serotonin reuptake inhibitors (SSRIs) relative to 
placebo in the treatment of childhood OCD (Geller et al., 2003).   
 Cognitive behavioral therapy has produced high treatment response rates at both 
post-treatment and follow-up time points in a number of studies (e.g., Barrett, Healy-
Farrell, & March, 2004; Storch, Geffken, et al., 2007; POTS, 2004).  A current meta-
analysis of randomized controlled trials (RCTs) of SSRIs and CBT for childhood OCD 
found that both treatment modalities were efficacious (Watson & Rees, 2008) with the 
effect size for CBT (d = 1.45) substantially larger than for SSRIs (d = 0.48), noting that 
CBT alone is more efficacious than medication alone in the treatment of childhood OCD.    
Among specific studies, in a 14-week, randomized, wait-list controlled trial (n = 77; ages 
7-17 years), Barrett et al. (2004) found that both individual and group CBT were superior 
to a wait-list control.  Treatment gains were maintained at a 7-year follow up (O'Leary, 
Barrett, & Fjermestad, 2009). Combination therapy with CBT and SSRIs has also shown 
efficacy in the treatment of OCD.  In a 12-week, multi-center, randomized, placebo-
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controlled treatment study looking at the efficacy of individual CBT, sertraline, and their 
combination in children with OCD (n = 112; ages 7-17 years), all three treatments had 
significantly greater decreases in symptoms relative to the placebo group.  The combined 
treatment and CBT alone arms demonstrated higher remission rates relative to sertraline 
and placebo (POTS, 2004). Indeed, practice parameters suggest the use of CBT alone for 
mild and moderate cases, and multimodal cases for severe cases only (POTS, 2004).    
Cognitive behavioral therapy incorporates psychoeducation, cognitive training 
and exposure and response prevention (E/RP).  Exposure and response prevention is a 
critical component to the treatment method whereby individuals are systematically 
exposed to feared stimuli gradually moving from low-anxiety exposures to high-anxiety 
exposures without engaging in the ritual.  The exposure component is based on the idea 
that anxiety should eventually abate after an individual is exposed to the feared stimuli 
for a sufficient amount of time (Dar & Greist, 1992).  During exposures, individuals are 
prevented from engaging in compulsions to relieve their distress.  Fear extinction is 
facilitated through this process where systematic and repeated exposures to the feared 
stimuli occur in the absence of compulsions.  Successful exposures result in habituation, 
where individuals begin with high anxiety at the beginning of the exposure and 
experience a substantial decrease in anxiety by the end of the exposure.  These exposures 
are practiced both during therapy and at home in between sessions. Since exposure 
exercises can be anxiety provoking and time intensive, some patients consider E/RP to be 
aversive and are not willing to participate in these treatment methods (Franklin & Foa, 
1998; McDonald & Blizard, 1988).  Therefore, the success of the therapy relies heavily 
on the individual’s willingness to engage in the exposures both in and out of sessions.   
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Although CBT and CBT and SSRI combination therapy boast high rates of 
treatment response, remission rates are not robust.  In the aforementioned POTS (2004) 
study, remission rates for children receiving CBT alone, SSRI alone, and CBT and SSRI 
combination were 39%, 21%, and 53.6% (POTS, 2004), indicating that a substantial 
number of patients relapsed and remained symptomatic at follow-up.  Maintenance of 
treatment gains is a common concern in OCD treatment, particularly since CBT 
therapists are not readily available, and a substantial number of patients need to travel 
long distances to obtain appropriate treatment.  Although CBT and SSRI combination 
therapy has higher remission rates relative to CBT or SSRI monotherapy, some parents 
are reluctant for their child to take psychotropic medications (Stevens, Wang, Fan, 
Edwards, Campo, & Gardner, 2009).  Additionally, due to the time consuming and 
modestly aversive nature of E/RP, some patients refuse to participate in therapy and/or 
eventually drop out of treatment (Schruers, Koning, Luermans, Haack, & Griez, 2005; 
Storch, Geffken, et al., 2007).  Due to these commonly encountered issues, innovative 
research has begun to focus on methods of augmenting CBT by utilizing d-cycloserine 
(DCS) as an adjunctive medication to facilitate fear extinction during exposures (Chasson 
et al., 2010; Kushner et al., 2007; Storch Murphy, et al., 2010; Wilhelm et al., 2008) 
D-cycloserine augmentation of CBT 
D-cycloserine is a partial agonist that acts on the strychnine-insensitive glycine-
recognition site of the N-methyl-D-aspartate (NMDA) glutamatergic receptor complex.  
NMDA antagonists are known to block fear extinction and learning; conversely, NMDA 
agonists have recently been shown to enhance fear extinction learning (e.g., Ledgerwood, 
Richardson, & Cranney, 2003; Walker, Ressler, Lu, & Davis, 2002). Extinction does not 
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refer to the unlearning of associations; instead it involves the formation of new 
associations that compete with the original aversive associations (e.g., Davis, Falls, & 
Gewirtz, 2000; Falls & Davis, 1995). Historically used as a second-line antibiotic for 
tuberculosis, DCS is relatively benign with infrequent side affects. Among the eight 
human studies utilizing DCS as an adjunct to psychotherapy, there have been few to no 
serious adverse events (e.g., Kushner et al., 2007; Ressler et al., 2004; Storch, Murphy, et 
al., 2010; Wilhelm et al., 2008). 
Several studies have shown the potential for DCS to facilitate fear extinction in 
both animals and humans (Davis, Ressler, Rothbaum, & Richardson, 2006; Hofmann, 
Pollack, & Otto, 2006; Norberg, Krystal, & Tolin, 2008). Animal studies have 
demonstrated the potential for enhanced fear extinction learning when fear extinction 
training is augmented with DCS.  Walker et al. (2002) first showed that acute doses of 
DCS prior to extinction training facilitated extinction of learned fear in rats with 
extinction training, but not in rats without extinction training, suggesting that results were 
due to enhanced fear extinction learning caused by the DCS, not by any anxiety-reducing 
properties of DCS.  Using a similar paradigm, Ledgerwood et al. (2003) found that DCS 
enhanced fear extinction in rats when administered either soon before or after extinction 
training, indicating that DCS may facilitate both the acquisition and consolidation of 
memories.  Furthermore, Ledgerwood et al. (2004) demonstrated that rats that were 
previously administered DCS during the extinction training did not exhibit a 
reinstatement effect when re-exposed to the original aversive association, while the rats 
that were not administered DCS during extinction training, did exhibit a reinstatement 
effect.  Collectively, these results have important clinical implications. In the context of 
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OCD treatment, administration of DCS may be able to decrease relapse of symptoms 
after the completion of treatment, thereby increasing remission rates.   
The adult anxiety literature has shown promising evidence regarding the potential 
for DCS to facilitate fear extinction during exposure sessions (Guastella et al., 2008; 
Hofmann, Meuret, et al., 2006; Otto et al., 2010; Ressler et al., 2004). Exposure therapy 
is a form of extinction learning where repeated exposures to the feared stimuli eventually 
lead to the habituation of the feared stimuli. Ressler et al. (2004) found in a double-
blinded, placebo-controlled study with 27 adults with acrophobia that DCS (50 or 500 
mg) administered 2-4 hours prior to exposure therapy significantly decreased acrophobia 
symptoms after the first exposure session relative to those that receive placebo.  Those in 
the DCS group maintained their treatment gains at 3-month follow up.  In a randomized, 
double blind, placebo-controlled study, Hofmann et al. (2006) examined the use of DCS 
as an adjunct to exposure therapy in a group of 27 adults with social phobia.  Those who 
received DCS (50mg) 1 hour prior to exposure therapy experienced greater 
improvements at post-treatment and 1-month follow up relative to the placebo and 
exposure therapy group.  Similarly, Guastella et al. (2008) found in a randomized, 
double-blind placebo-controlled study with 56 adults with social anxiety disorder that 
those who received DCS (50mg) 1 hour prior to exposure therapy had significantly 
reduced social anxiety symptoms at post-treatment relative to placebo. Progress of the 
patients was tracked on a weekly basis and significantly greater reductions in social 
anxiety symptoms were identified on the 3rd administration of DCS during an exposure 
session. Otto et al. (2010) found positive results in a randomized, double-blind, placebo-
controlled, 5-session CBT trial with 31 adults with panic disorder with or without 
 7
agoraphobia.  Those who received DCS (50mg) 1 hour before sessions 3-5 had 
significantly greater reductions in panic symptoms at post-treatment relative to those who 
received placebo.  Treatment gains of the DCS group were maintained at 1-month follow 
up.   
There are three published studies regarding DCS and E/RP Ω for adult OCD 
(Kushner et al., 2007; Storch, Merlo, et al., 2007; Wilhelm et al., 2008) and one in 
pediatric OCD (Storch, Murphy, et al., 2010). All studies were randomized, double-blind, 
and placebo-controlled.  Kushner et al. (2007) found that those who received 125 mg of 
DCS 2 hours before E/RP had significantly lower levels of obsession-related distress after 
4 E/RP sessions relative to those who received placebo.  The DCS+E/RP group reached a 
decrease of more than 50% reduction of subjective units of distress scale (SUDS) two 
sessions more quickly than those in the placebo group. Wilhelm et al. (2008) conducted a 
study with 23 patients with a primary diagnosis of OCD and found that after 5 exposure 
sessions, those who received 100 mg of DCS one hour prior to each E/RP session had 
significantly lower OCD severity scores than the placebo group (Cohen’s d = 0.63), 
indicating that DCS enhanced fear extinction and significantly increased the pace of 
symptom reduction in those with OCD (Chasson et al., 2010).  Storch et al. (2007) (n = 
24) did not find significant differences at post-treatment or follow up between the 
DCS+E/RP and placebo+E/RP group.  Both groups improved significantly from pre- to 
post-treatment.  Null findings are likely due to methodological differences as patients 
were administered 250 mg of DCS four hours prior to the E/RP sessions (versus 1-2 
hours) and prior studies with positive findings generally used lower doses.     
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Currently, there is only one published study on the effect of DCS as an adjunct to 
CBT in children with OCD.  Storch et al. (2010) conducted a randomized, double-blind, 
placebo-controlled DCS+E/RP treatment trial on 30 children and adolescents (ages 8-17 
years) with a primary diagnosis of OCD.  Both the placebo+E/RP and DCS+E/RP groups 
improved significantly from pre- to post-treatment.  At post-treatment, significant 
differences and large effect sizes were found on the Clinical Global Impressions-Severity 
(CGI-Severity) scale (National Institute of Mental Health, 1985), which is a measure of 
global functioning severity, between the DCS+E/RP and placebo+E/RP groups (p < .05, 
Cohen’s d = .91).   Additionally, at post-treatment, differences between the two groups 
approached significance (p = .08) and produced moderate effect sizes (Cohen’s d = .67) 
on the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS; Scahill et al., 
1997), a measure of OCD severity, favoring the DCS+ERP group.  Group by time 
interactions produced small to moderate effect sizes in favor of the DCS+E/RP group on 
the CY-BOCS (Cohen’s d = .31) and CGI-Severity (Cohen’s d = .47), indicating that 
DCS+E/RP may positively enhance E/RP in children with OCD.    
 Increasing evidence shows the potential benefits of utilizing DCS as an adjunct 
for exposure sessions in CBT. Improved treatment response may be hypothesized to be a 
function of increased compliance and engagement in therapeutic homework tasks.  This 
may be because as DCS facilitates fear extinction during exposure sessions, the enhanced 
association learning makes practicing exposures independently less aversive and easier to 
complete.  To date, there is no information regarding the relationship between DCS and 
homework compliance.  Homework assignments are an integral component of CBT 
regardless of diagnosis to achieve a meaningful outcome (e.g., Shelton & Levy, 1979).  
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Given this, E/RP sessions typically end with assigning the patient homework based on 
session content that lasts up to 60 minutes per day.  Between sessions, individuals are 
instructed to practice E/RP tasks and cognitive strategies used during therapy to enhance 
generalization.   
Cognitive-behavioral models of OCD suggest that faulty interpretations of 
intrusive thoughts, images, and doubts actuate ritualistic behaviors (Salkovskis, 1985, 
1999).  Rituals are then maintained through negative reinforcement as the behaviors serve 
to temporally reduce anxiety and distress induced by the obsessions.  Therefore, clinical 
improvement requires the individual to habituate to the anxiety caused by the obsessions.  
As previously mentioned, E/RP serves as fear extinction training by exposing the 
individual to the feared stimuli and removing the reinforcement effect of compulsions.  
By repeatedly exposing the individual to the anxiety trigger and preventing the 
corresponding rituals, the relationship between the previously feared stimuli eventually 
becomes non-anxiety provoking and the conditioned response to the stimuli (compulsions 
and rituals) is extinguished.  For these reasons, homework is a crucial component to CBT 
as it directs the individual to continuously engage in behaviors that will weaken the 
behavioral relationship between the feared stimuli and associated compulsions.    
The relationship between homework compliance and CBT  
To date, a number of studies have examined the role of psychotherapeutic 
homework compliance among varied adult psychiatric disorders, outside the context of 
DCS augmentation.  Adult depression studies have consistently shown that homework 
compliance is predictive of enhanced treatment outcome (e.g., Addis & Jacobson, 2000; 
Coon & Thompson, 2003; Kazantzis, Deane, & Ronan, 2000; Neimeyer, Kazantzis, 
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Kassler, Baker, & Fletcher, 2008).  For example, in a CBT trial for 20 adults with 
depression, mid-treatment homework compliance significantly contributed to the 
prediction of mid-treatment change.  When combined with ratings of acceptance of 
treatment rationale, the two variables accounted for 8% of the variance in change (Addis 
& Jacobson, 2000).  Burns and Spangler (2000) have suggested a direct causal effect 
between greater homework compliance and better treatment outcome.  In 521 depressed 
adults who had completed CBT, a causal effect of homework compliance on post-
treatment depressive symptoms was -4.32 (CR=-2.89, p < .01), indicating a strong 
association between increased homework compliance and decreased depressive 
symptoms.       
The adult anxiety literature on the association between homework compliance and 
treatment outcome has produced inconsistent results (Abramowitz, Franklin, Zoellner, & 
DiBernardo, 2002; Edelman & Chambless, 1993; Leung & Heimberg, 1996; Schmidt & 
Woolaway-Bickel, 2000; Woods, Chambless, & Steketee, 2002; Woody & Adessky, 
2002).  A meta-analysis examining the relationship between homework compliance and 
treatment outcome in adult depression and anxiety CBT trials found a medium effect size 
of 0.36 (Kazantzis et al., 2000).  However, when analyses separated the effects by 
diagnostic class, the association between homework compliance and treatment outcome 
was substantially weaker for anxiety trials than for depression trials. This is reflective of 
the adult anxiety literature as some trials show strong associations between homework 
compliance and treatment outcome (Edelman & Chambless, 1993; Schmidt & 
Woolaway-Bickel, 2000) while others show no relationship (Leung & Heimberg, 1996; 
Woody & Adessky, 2002).   
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Very little is known about homework compliance and treatment outcome in 
children and adolescents.  Hughes and Kendall (2007) conducted the only published 
study examining this association in children 9-13 years old diagnosed with overanxious 
disorder, separation anxiety disorder, or avoidant disorder.  Therapists rated homework 
compliance on a 1-7 Likert scale based off of the patient’s report.  Investigators found no 
significant relationship between homework compliance and treatment outcome.   
There is little empirical research specifically examining homework compliance 
and treatment outcome in the OCD literature (De Araujo, Ito, & Marks, 1996; Lax, 
Basoglu, & Marks, 1992; O'Sullivan, Noshirvani, Marks, Monteiro, & Lelliott, 1991; 
Simpson et al., 2011).  O’Sullivan et al. (1991) found in 34 adults with OCD (ages 18-60 
years) that treatment compliance significantly predicted treatment outcome at 6-year 
follow up. Abramowitz et al. (2002) found similar results in 28 adults with OCD (ages 
18-65 years) after 18 CBT sessions; general CBT compliance was associated with OCD 
treatment response.  Treatment compliance comprised of understanding of the treatment 
rationale, compliance within sessions and homework compliance.  Homework 
compliance was rated by the clinicians and determined based off of collected homework 
forms and verbal reports from the patient.  Better understanding of the rationale was 
associated with increased compliance within sessions; greater compliance within sessions 
was associated with greater homework compliance.  When pre-treatment severity scores 
were controlled for, treatment compliance accounted for 64% of the variance of the post-
treatment OCD severity scores (p < .01). De Araujo et al. (1996) identified homework 
compliance during the first week of treatment to be the best predictor of treatment 
outcome in 46 adult OCD outpatients.  Homework adherence was calculated as the 
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percentage of completed homework (as determined by the clinician) versus agreed upon 
homework.  Most recently, Simpson et al. (2011) found in 30 adults with OCD that 
homework compliance, as well as early homework adherence (sessions 5-9) significantly 
predicted lower OCD severity after 18 CBT sessions.  Homework compliance was 
measured by the Patient EX/RP Adherence Scale (PEAS), which took into account 
quantity of homework (percentage of assigned exposures attempted), quality of 
homework (how well the exposures were completed), and degree of ritual prevention 
(how successful was the patient in resisting compulsions).   
In contrast to the above positive relationships, Lax et al. (1992) examined E/RP 
treatment compliance as a predictor of CBT outcome in 49 adults with OCD (ages 18-60 
years) but found no relationship between compliance and treatment outcome; however, 
these results may be due to lack of variance within the sample, as the group had generally 
high rates of compliance throughout the study. Woods et al. (2002) also found that higher 
homework compliance throughout treatment was associated with higher post-treatment 
anxiety symptoms in 82 individuals with OCD or panic disorder with agoraphobia.  On 
balance, this effect was small and although there was a considerable amount of variance 
in the homework compliance, in general homework compliance was low.  Thus, it is 
possible that if overall homework compliance in the sample were higher, the effect may 
not have been produced.       
The discrepancies in findings in the OCD and anxiety literature may be because 
each study used different methods of determining homework compliance.  Some trials 
rated homework adherence based on the quantity of homework completed (how much 
time was spent practicing the exposure), others on the quality of homework (the amount 
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of distress/anxiety reached and whether habituation was achieved), and a few considered 
both quantity and quality.  Additionally, trials differed as to whether the ratings were self-
report or clinician-administered.  Unfortunately, no universal measure of homework 
compliance in CBT exists given differences in treatment approach as a function of 
disorder; therefore, other than the study conducted by Simpson and colleagues (2011), the 
validity and the reliability of the homework compliance measures used in the studies 
have not been determined.   
Thus, whether the underlying constructs between homework compliance and 
treatment outcome are associated is still unclear. In the context of CBT augmented with 
DCS, DCS may indirectly cause homework adherence to become easier due to the 
enhanced facilitation of extinction learning during the therapy sessions.  Previously 
mentioned studies have shown that DCS administration is associated with improved 
treatment outcomes (e.g., Storch, Murphy, et al., 2010; Wilhelm et al., 2008), which 
theoretically may make individuals more likely to engage in CBT homework between 
sessions. Should this relationship exist, it may provide a mechanism through which DCS 
impacts treatment outcome.  Outside the context of DCS, the anxiety homework 
compliance literature has provided discrepant findings regarding the impact of homework 
adherence on treatment; therefore, the question about the relative contribution of 
homework to treatment outcome remains unclear.   
 With this in mind, the primary aim of this study is to examine whether DCS 
combined with E/RP would be related to improved homework compliance relative to 
placebo augmentation of E/RP in pediatric OCD and if homework compliance mediated 
the relationship between group assignment and treatment outcome.  It is hypothesized 
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that the DCS combined with E/RP group will be associated with greater homework 
compliance ratings and homework compliance will be a mediator between group 
assignment and treatment outcome.  Two exploratory aims were also examined. First, 
would DCS combined with E/RP be related to improved homework compliance relative 
to placebo combined with E/RP during the first half of the treatment trial (sessions 4-6) 
or the second half (sessions 7-10)?  Second, will baseline clinical variables, such as OCD 
severity, internalizing symptoms, externalizing symptoms, and depressive symptoms, 
predict homework compliance?  
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Method 
Participants 
Youth participated in an NIH-funded study examining DCS augmentation of CBT 
in children and adolescents with OCD (Storch, Murphy, et al., 2010).  Data were 
collected at two study sites: the outpatient psychiatric clinics at University of Florida and 
Massachusetts General Hospital.  The pre-existing treatment dataset consists of 30 
children and adolescent outpatients (34.4% female) diagnosed with primary OCD.  
Fifteen participants (50%) were randomized into the DCS condition, while the remaining 
15 received placebo.  Twenty-five participants (78%) completed all ten therapy sessions.  
Five participants (17%) made substantial improvements earlier in the trial and were able 
to complete the treatment program after session 8. Ages of participants ranged from 8-17 
years (M = 12.2, SD = 2.8 years).  In terms of race and ethnicity, 97% were Caucasian 
(N=29), 3% were Hispanic (N=1).  Twenty-two participants (73%) had one or more 
comorbid disorder and 15 participants (50%) were on concomitant psychotropic 
medication.  Participants were included in the study if they had a primary diagnosis of 
OCD, a Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) ≥ 16 (Scahill 
et al., 1997), no comorbid bipolar disorder, psychotic disorder, mental retardation, autism 
spectrum disorder, or substance abuse/dependence.  Participants were also included if 
they were English speaking and stable on psychotropic medication for at least 12 weeks 
(if applicable).  Participants with only hoarding symptoms were excluded.  Epilepsy, 
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renal insufficiency, pregnancy or generally poor physical health was exclusionary as 
well.  
Procedures 
All research procedures were reviewed and approved by the corresponding 
institutional review boards, and all parents and children provided written informed 
consent and assent prior to involvement in the respective treatment protocol.  An OCD 
diagnosis was ascertained before treatment through a clinical evaluation with an 
experienced psychiatrist or psychologist and confirmed through the Anxiety Disorders 
Interview Schedule for DSM-IV for Children: Child and Parent Version (ADIS-C/P; 
Silverman & Albano, 1996) by a trained independent evaluator.  The same independent 
evaluator administered the baseline, mid- and post-treatment CY-BOCS ratings 
thereafter. The Child Behavior Checklist and Child Depression Inventory were completed 
at baseline and post-treatment. Parent reports were collected from the primary caretaking 
parent; information regarding the primary caretaker (mother-report vs. father-report) was 
not collected.  Patients received up to ten 60-minute treatment sessions.  At the beginning 
of each session, therapists reviewed homework from the past week with the patient and 
completed the homework compliance rating scale.   
Physical examinations and laboratory tests (e.g., urine pregnancy and toxicology 
tests, blood count) were administered.  Participants were then randomized via computer, 
and clinicians, raters, and patients were blinded to medication status.  D-
cycloserine/placebo administrations were given one hour prior to sessions 4 through 10.  
Dosing was based according to weight; children who weighed between 25-45kg were 
given 25mg of DCS or placebo and children weighing ≥ 45 were given 50mg of DCS or 
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placebo (2 capsules were administered).  Dosages used were derived from findings from 
previous adult studies that indicated that approximately 0.7mg/kg was the most effective 
(Hofmann, Meuret, et al., 2006; Otto et al., 2010; Ressler et al., 2004; Wilhelm et al., 
2008).   
Measures 
Anxiety Disorders Interview Schedule for DSM-IV– Child and Parent Version 
(ADIS-C/P; Appendix A): The ADIS-C/P (Silverman & Albano, 1996) assesses current 
episodes of Axis I disorders and provides differential diagnosis based on DSM-IV-TR 
criteria (American Psychiatric Association, 2000).  The ADIS-C/P has consistently 
demonstrated strong psychometric properties, including test-retest reliability, inter-rater 
reliability, and concurrent validity (Silverman & Albano, 1996; Silverman, Saavedra, & 
Pina, 2001; Wood, Piacentini, Bergman, McCracken, & Barrios, 2002).  This measure 
was completed at screening, before baseline.  
Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS; Appendix 
B(Scahill et al., 1997): The CY-BOCS (Scahill et al., 1997) is a 10-item semi-structured 
clinician-administered measure of current obsession and compulsion severity.  The CY-
BOCS has demonstrated good psychometric properties (e.g. inter-rater reliability, internal 
consistency, test-retest reliability, discriminant validity, convergent validity) and is 
considered the gold-standard measure for OCD severity in youth (Scahill et al., 1997; 
Storch et al., 2004).  This was completed at screening, baseline, mid-treatment, and post-
treatment.   
Child Behavior Checklist (CBCL; Appendix C): The CBCL (Achenbach, 1994) is 
a widely used parent-rated questionnaire that assesses the intensity and frequency of 
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behavioral and emotional problems exhibited by children within the past 6 months. 
Composite scores for externalizing (e.g., inattentiveness, aggression) and internalizing 
(e.g. anxiety, depression) symptoms are provided by this measure.  The CBCL has 
exhibited good reliability, internal consistency and discriminant validity. 
Child Depression Inventory (CDI; Appendix D): The CDI (Kovacs, 1985) is a 21-
item self-report form that assesses the presence of depressive symptoms within the past 
two weeks. Responses range from not present (0) to severe (3).  The CDI has 
demonstrated good test retest reliability, internal consistency, construct validity, and 
concurrent validity (Kovacs, 1985). 
Clinical Global Impressions – Severity (CGI-Severity; Appendix E): The CGI-
Severity (National Institute of Mental Health, 1985) is a clinician-rated scale of global 
OCD severity rated on a 7-point Likert scale from 0 (no illness) to 6 (extremely severe).  
The CGI-Severity has been widely used in treatment studies and has demonstrated sound 
psychometric properties including convergent validity with the CY-BOCS and treatment 
sensitivity (Storch, Geffken, et al., 2007; Storch, Lewin, De Nadai, & Murphy, 2010).  
Homework Compliance Rating (HCR; Appendix F): HCR was completed by 
therapists at sessions 2-10 to measure the quantity and quality of homework adherence.  
Clinicians asked general prompts regarding homework compliance (i.e., how did your 
homework go this week?) at the beginning of each session. Ratings were determined 
based on the difficulty of exposures completed, amount of habituation experienced during 
the exposure, and the deliberateness of the exposure (accidental exposures to feared 
stimuli was not considered when completing the HCR). The rating scale was based on a 
7-point Likert scale ranging from 0 (“did not complete any assigned homework”) to 6 
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(“completed all homework and made efforts above and beyond assignments”).   The HCR 
ratings are modeled off the CGI-Severity scores; ratings for the HCR have similar 
anchors and scoring processes as the CGI-Severity, providing face validity for the HCR.  
Additionally, the HCR is moderately and significantly correlated with the post-treatment 
CGI-Severity (r = -.67) and the post-treatment CY-BOCS total score (r = -.65).  The 
significant negative correlations indicate the strong relationship between the HCR and the 
CY-BOCS and the CGI-Severity post-treatment scores (greater homework compliance is 
associated with decreased OCD symptoms and global severity), providing evidence for 
the construct validity of the HCR.  Additionally, the HCR was not significantly correlated 
with measures of delinquent behaviors and attention problems at post-treatment, 
providing evidence for discriminant validity for the HCR.  See Table 1 for data collection 
time points. 
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Analytic Plan 
Specific Aim 1.  To examine whether group assignment (DCS or placebo) would 
be related to homework compliance, a random effects model will be employed.   The 
random effects model will be fit with random intercept and slopes.  The model will 
incorporate treatment group, patient level random intercept and a random group by time 
interaction term. The model will be used to test whether the slopes between the two 
treatment groups were significantly different over the 7 sessions.   A significant 
interaction will indicate that group assignment predicts homework compliance over time.  
The previously published Storch et al. (2010) study, given its preliminary nature, lacked 
sufficient power to detect small to medium post-treatment differences; however, the 
multiple measurement points utilized in the random effects model for the present analyses 
will substantially increase power.  Power analyses demonstrated that given a sample of N 
= 30, we will have a power of .80 to detect ‘medium’ sized (f = .18) interaction effects. 
To examine the relationship between group assignment, homework compliance, 
and treatment outcome (post-treatment CY-BOCS), a mediation analysis will be 
conducted.  Bootstrapping methods will be utilized to determine if homework compliance 
is a mediator of group assignment and treatment outcome, with group assignment 
predicting treatment outcome.  A 95% confidence interval will be determined by 
resampling the provided sample k=5,000 times.  The exclusion of zero between the lower 
and upper bounds of the confidence interval will indicate that the indirect effect of the 
mediator on the outcome is not zero with 95% confidence (Hayes 2009).  
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Exploratory Aim 1.  To examine whether group assignment (DCS or placebo) 
would be related to homework compliance during the first half or second half of 
treatment sessions, a random effects model will be employed.  Sessions will be 
categorized into two groups: sessions 4-6 (first half) and sessions 7-10 (second half).  
Again, the random effects model will be fit with random intercept and slopes.  The model 
will incorporate treatment group, patient level random intercept and a random group by 
time interaction term. The model will be used to test whether the slopes between the two 
treatment groups were significantly different in the first half or the second half of the 
treatment trial.  Power analyses demonstrated that given a sample of N = 30, we will have 
a power of .80 to detect ‘medium’ sized (f = .24 for earlier sessions, f = .22 for latter 
sessions) interaction effects.  
Exploratory Aim 2: To examine whether internalizing symptoms (CBCL), 
externalizing symptoms (CBCL), depressive symptoms (CDI-SF) and baseline OCD 
symptom severity (CY-BOCS) are predictors of homework compliance, four linear 
regression analyses will be conducted.  Homework compliance will be measured by 
utilizing the average of homework compliance scores for each individual. Significant 
relationships will be determined by setting R2 significance at p < .05 level for each 
predictor.   
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Results 
Relationship between group assignment and homework compliance over time 
A mixed model analysis examining the relationship between group assignment 
(DCS or placebo) and homework compliance was conducted.  The mean homework 
compliance score at the first exposure session (session 4) was 4.26.  Relative to the no 
growth model, the unconditional growth model did not provide a better fit (see Table 2); 
time parameters for the unconditional growth model were not significant, indicating that 
there was no change in homework compliance over time.  A random effects model was 
employed and revealed no significant group x time interaction; however, there was a 
significant effect for group (Table 2). Results indicate that the placebo group scored 1.02 
points less on homework compliance ratings at the first exposure session than the DCS 
group.   
 Mixed model analyses examining the relationship between group assignment 
(DCS or placebo) and homework compliance during the first half (sessions 4-6) and 
second half of treatment sessions (sessions 7-10) were conducted.  The mean homework 
compliance score at the first exposure session (sessions 4 and 7, respectively) was 4.27 
for sessions 4-6 and 4.31 for sessions 7-10.  However, the unconditional growth model 
did not provide a better fit than the no growth model for both the first half of sessions 
(Table 3) and the second half of sessions (Table 4); time parameters were not significant 
for either.  
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The relationship between overall homework compliance scores across groups 
(DCS and placebo combined) and treatment outcome was further examined via mixed 
model analyses.  The mean CY-BOCS score at baseline was 35.07.  The random effects 
model revealed a significant homework compliance-by-time interaction (F(2, 30) = 9.22, 
p < .01; Table 5).  Results indicate that as mean homework compliance increases by one 
point, CY-BOCS scores decrease 1.54 points for each assessed time point.  
Mediational analysis 
Bootstrapping meditational analysis revealed that homework compliance was a 
mediator of group assignment and treatment outcome (CI = .60-6.76; Table 6).  The 
direct effect between group assignment and treatment outcome approached significance 
(p = .08).  After including the impact of homework compliance into the meditational 
model, the indirect effect between group assignment and treatment outcome no longer 
approached significance (p = .53), which indicates that the influence of the group 
assignment on treatment outcome goes through homework compliance.  
Predictors of homework compliance 
 Externalizing symptoms significantly predicted homework compliance (b = -.36, 
t(29) = -2.05, p ≤ .05), while baseline OCD severity approached significance (b = -.35, 
t(29) = -1.99, p = .06; see Table 7).  Internalizing and depressive symptoms did not 
predict homework compliance (b = -.07, t(29) = -.36, p = .72; (b = -.14, t(29) = -.75, p = 
.46).  
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Discussion 
 The present study examined the relationship between DCS group status and 
homework compliance.   Results revealed that DCS group status was not associated with 
improved homework compliance over the course of treatment. Rather, as the data was not 
a better fit with the unconditional growth model (relative to the no growth model), the 
results indicated that homework compliance may be a stable variable that does not 
change over time.  In other words, individuals with initial high homework compliance 
ratings continued to have high ratings throughout treatment, while those with low 
homework compliance ratings continued to have low ratings throughout treatment. 
Levels of motivation may also be associated with homework compliance ratings; those 
who were more motivated during therapy may have been more engaged and compliant 
during exposure sessions and while completing homework tasks, while those who were 
less motivated may have exerted substantially less effort throughout treatment. As 
motivation is a predictor of treatment response (Vogel, Hansen, Stiles, & Gotestam, 
2006), assessing the patient’s motivation during the first few session can provide 
important information regarding the patient’s treatment prognosis.   
Although DCS group status was not associated with change in homework 
compliance, homework compliance mediated the relationship between DCS group status 
and treatment outcome.  Because the group x time interaction within the random effects 
model was not significant, these results indicate that increased homework compliance, 
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regardless of time, may be related to better treatment outcome. However, bootstrapping 
results revealed a significant relationship between group status and homework 
compliance (p=.04), indicating that group status differentiated homework compliance in 
some manner.  Additionally, at the first exposure session (session 4), the DCS group had 
significantly greater homework compliance scores relative to the placebo group.  This 
indicates that from the first exposure session, there were differences between the two 
groups and these differences in homework compliance continued throughout treatment.  
These findings may perhaps be because the DCS group had slightly less severe pre-
treatment OCD severity than the placebo group.  Additionally, the lack of significant 
findings in the group x time interaction may be due to insufficient power to detect these 
effects, the psychometric constraints of the homework compliance measure, the fact that 
error is compounded by multiplication of variables, or a non-linear interaction between 
the variables.  
Consistent with previous adult OCD research (Abramowitz et al., 2002; De 
Araujo et al., 1996; Simpson et al., 2011), homework compliance inversely predicted 
post-treatment OCD severity when the sample was collapsed. That is, the more the child 
engaged in homework exposures (e.g., exposures that lead to habituation), the more the 
child was rated to have improved at both mid- and post-treatment time points. Taken 
together, these findings suggest that good homework compliance is essential for success 
in treatment. However, as quality and quantity of homework compliance does not tend to 
change over time, it is important that patients and their families exhibit good homework 
adherence from the beginning of treatment.  Clinicians should emphasize the importance 
of homework compliance early on, discuss the nature of homework (e.g., what homework 
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will consist of), agree upon homework exposures and goals, explain implementation of 
exposures, and stress the necessity of frequent exposure exercises between sessions.  
Since treatment compliance is unlikely to change over time (i.e., those who are 
noncompliant at early sessions, are likely to be non compliant at later sessions), 
compliance should be assessed at every session.  Clinicians should then intervene and 
address issues regarding compliance as soon as it is identified.  Motivational interviewing 
strategies such as decisional balancing (weighing out the good and less good aspects of 
their behavior to promote change) and eliciting change talk (having the patient come up 
with ways their lives will change if the behavior changes) can be included in sessions 
where individuals show low motivation or poor homework compliance at treatment onset, 
so as to address these issues directly and early on.    
Regarding clinical predictors of homework compliance, externalizing symptoms 
and increased baseline OCD severity were negatively associated with homework 
compliance but depressive and internalizing symptoms were not.   Children with 
increased externalizing symptoms may be more oppositional when asked to complete 
exposures for homework by refusing to practice exposures or not completing exposures 
to habituation.  Additionally, parents with children exhibiting externalizing symptoms 
may engage in more family accommodation (i.e., modify activities due to child’s 
obsessive-compulsive symptoms, do things for the child, participate in child’s rituals), so 
to avoid temper tantrums or arguments. Alternatively, children with externalizing 
symptoms may purposefully throw temper tantrums so that family members will 
accommodate their obsessive-compulsive symptoms.  Those with more severe obsessive-
compulsive symptoms may find exposures to be too aversive and thus may not be able to 
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complete homework exposures properly. Their symptoms may also be too impairing and 
cause too much distress and anxiety, making it substantially more difficult for the 
individual to be able to engage in homework exposures.    
This study is the first to examine the relationship between DCS and homework 
compliance and also adds to the literature on homework compliance in pediatric anxiety 
disorders.  This study has several limitations.  First, the sample size is modest and may 
not be generalizable to the pediatric OCD population; therefore, replication of this study 
in a larger sample.  Second, although therapists carefully assessed homework compliance 
at the beginning of each session, a one-item measure of homework compliance may not 
have captured all the nuances of homework compliance.  Therefore, ratings may have 
been constrained by the nature in which the questions were asked, making homework 
compliance ratings susceptible to floor and ceiling effects and difficult to measure any 
potential for change.  Third, there was no independent verification of homework 
compliance.  A clinical synthesis of all available information was utilized to determine 
the level of homework adherence; however, parent and/or child may have presented a 
more favorable representation of homework completion.  Additionally, because the initial 
treatment study was not designed to specifically focus to on homework compliance 
ratings, homework compliance ratings were not checked for inter-rater reliability. Thus, it 
may be possible that therapists did not rate homework compliance in a standardized 
manner.  Finally, other salient variables that may have affected the levels of homework 
compliance and/or improvements in OCD severity throughout treatment, such as 
motivation or insight, were not assessed in the present study.  
 Overall, this study provides important information for both the DCS and anxiety 
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homework compliance literature.  First, homework compliance is an important 
component of E/RP for children and adolescents with OCD.  Increased homework 
compliance not only significantly predicted better treatment outcome, but also mediated 
the effects of DCS on treatment outcome.  Although the exact effect of DCS on 
homework compliance is unknown, it is clear that increased homework compliance is a 
good prognostic indicator.  Second, obtaining homework compliance early on in 
treatment is essential as homework adherence may be unlikely to change over time.  
Therefore, homework compliance should be thoroughly assessed and obstacles that may 
interfere with homework compliance should be readily addressed. Finally, due to the 
importance of early homework compliance in treatment outcome, future research should 
examine possible predictors of decreased homework compliance and investigate methods 
of increasing homework compliance prior to the start of treatment. Comorbidity, 
motivation, insight, developmental age, family functioning, and socioeconomic status are 
all possible variables that may in some way affect homework compliance.  
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Footnote 
Ω
 In this text, exposure and response prevention (E/RP) and cognitive behavioral therapy 
(CBT) are the same and utilized interchangeably.   
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Appendix 1 
 
Tables 
 
Table 1. 
Assessment Schedule 
 
Measures Screening Baseline Sessions 
2-4 
Mid-
Treatment 
(Session 
5) 
Sessions 
6-9 
Post 
Treatment 
(Session 
10) 
ADIS-C/P X     X 
CY-BOCS X X  X  X 
CBCL  X    X 
CDI  X    X 
CGI-S  X  X  X 
HCR   X X X X 
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Table 2. 
Random effects model for homework compliance scores with DCS group assignment 
(with and without time effects) 
 
 No Growth Unconditional Growth Conditional Growth 
-2loglikelihood 642.804 642.745 634.915 
   ∆-2loglikelihood  .059 7.83 
Parameters 3 4 5 
   ∆ Parameters  1 1 
  χ² (1, N=30) =3.84) χ² (1, N=30) =3.84) 
Fixed Effects    
   Intercept 4.29 (.17) p<.001** 4.26 (.2), p<.001** 5.79 (.59), p<.001** 
   Time   .01(.04), p=.81 -.07(.13), p=.57 
   Group   -1.02(.37), p=.008* 
   Time x Group   .06(.08), p=.49 
Note. *p<.01, **p<.001 
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Table 3. 
Random effects model for homework compliance scores with DCS group assignment 
(with and without time effects) for sessions 4-6 
 
 No Growth Unconditional Growth 
-2loglikelihood 304.901 304.867 
   ∆-2loglikelihood  .034 
Parameters 3 4 
   ∆ Parameters  1 
  χ² (1, N=30) =3.84). 
Fixed Effects   
   Intercept 4.27 (.17), p<.001** 4.25 (.26), p<.001** 
   Time   .03(.14), p=.85 
Note. **p<.001 
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Table 4. 
Random effects model for homework compliance scores with DCS group assignment 
(with and without time effects) for sessions 7-10 
 
 No Growth Unconditional Growth 
-2loglikelihood 342.106 342.104 
   ∆-2loglikelihood  .002 
Parameters 3 4 
   ∆ Parameters  1 
  χ² (1, N=30) =3.84). 
Fixed Effects   
   Intercept 4.31(.17), p<.001** 4.29 (.42), p<.001** 
   Time   .01(.04), p=.96 
Note. **p<.001 
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Table 5. 
Random effects model for CY-BOCS scores with homework compliance and time effects 
 
Parameters CY-BOCS p 
Effects   
   Intercept 35.07(5.55) .00** 
   Time -1.38(2.39) .57 
   Homework Compliance -.46(1.25) .72 
   Time x Homework Compliance -1.54(.54) .006** 
Note. **p<.001 
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Table 6. 
 
Results of analyses examining homework compliance as a mediator between group status 
and treatment outcome 
 
 Β SE p 
a -.66 .31 .04* 
b -4.43 1.12 .0005** 
c 4.2 2.31 .08 
c’ 1.27 2.01 .53 
 Estimate SE 95% CI 
Indirect effect 2.85 1.51 .60-6.76 
Note. c = direct effect, c’ = indirect effect; *p< .05, **p<.001 
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Table 7.  
Predictors of average homework compliance 
 
Predictor B SE(B) b t p 
CDI -.04 .06 -.14 -.75 .46 
CBCL-Internalizing -.007 .02 -.07 -.36 .72 
CBCL-Externalizing -.05 .02 -.36 -2.05 .05 
Baseline CY-BOCS -.08 .04 -.35 -1.99 .06 
Note. CDI = Children’s Depression Inventory; CBCL-Internalizing = Child Behavior 
Checklist – Internalizing symptoms; CBCL-Externalizing = Child Behavior Checklist – 
Externalizing symptoms; CY-BOCS = Children’s Yale-Brown Obsessive Compulsive 
Scale. 
 
 
 
 
 
 
 
 
 
 
